24th Annual Market Access Summit 2025

20+ HOURS OF INNOVATIVE CONTENT

10+ HOURS OF NETWORKING

30+ TOP MARKET ACCESS SPEAKERS

93% OVERALL ATTENDEE SATISFACTION AT PREVIOUS EDITIONS

WHERE POLICY, INNOVATION, & ACCESS CONVERGE

Join us at the 24^th Annual Market Access Summit in fall 2025! This premier event brings together market access leaders, policy experts, and industry innovators from across the healthcare landscape. Register now to connect, learn, and shape the future of patient access in Canada.

Navigate HTA and reimbursement frameworks across provinces.
Craft effective stakeholder engagement
Harness real-world evidence to drive access and funding decisions.
Leverage data and analytics to inform market access planning.
Align policy, pricing, and innovation to ensure sustainable access for patients.

This summit features notable organizations, including Canada’s Drug Agency (CDA-AMC), Gilead Sciences, Sandoz Canada, the PMPRB, AbbVie, the pCPA, and many more!

REGISTER NOW

CONNECT WITH YOUR PEERS IN INTERACTIVE SESSIONS

Don’t miss the unique opportunity to connect, engage, and learn with top market access and reimbursement experts! With a range of dynamic formats and plenty of chances to have fun and unwind, this is an experience you won’t want to miss. You can look forward to:

Interactive sessions and roundtable discussions
Curated breakout learning opportunities
Face-to-face networking (including speed networking)
Virtual streaming for greater accessibility
A breakfast, lunch, and evening drinks reception

REGISTER NOW

DRIVE PATIENT ACCESS & SHAPE SUSTAINABLE INNOVATION

Enhance access to pharmaceuticals and MedTech with patient-focused strategies. Delve into all the hottest topics discussed over two incredible days.

Hear the latest government guidance directly from the President and CEO of Canada’s Drug Agency (CDA-AMC).
Learn innovative approaches to reimbursement for both private and public payers with insights from the pCPA and the PMPRB.
Better understand how pathways to market access can be optimized with insights from Bayer, Cystic Fibrosis Canada, and others.
Define what value means to different stakeholders with experts from AbbVie and Eisai Canada.
Navigate the challenges and opportunities of international market access with leaders from Gilead Sciences and Sandoz.

VIEW AGENDA

OUR DELEGATES INCLUDE:

WHO SHOULD ATTEND?

Whether you’re focused on reimbursement, pricing strategy, patient experience or real-world evidence, this summit delivers the insights and connections you need to drive meaningful access for patients across Canada.

WHO WILL BENEFIT FROM THE EVENT?

Senior Executives From:

Pharmaceuticals: Market Access, Government Affairs, Health Technology Assessment (HTA) and Reimbursement, Real-World Evidence, Pharma Economics, Pricing, Patient Access Programs, Medical Affairs
BioTech: Market Access, Government Affairs, HTA and Reimbursement, Real-World Evidence, Pharma Economics, Pricing, Patient Access Programs, Medical Affairs
MedTech: Market Access & Reimbursement, Health Economics and Outcomes Research (HEOR), Value-Based Partnerships, Strategic Policy
Provincial: Drug Programs, Health System Planning, Reimbursement and Coverage, Policy, Public Drug Plans, Health Innovation Strategy, Health Technology Assessment (HTA)
Federal: Market Access, Policy, Health Economists, Senior Policy Analysts, Regulatory Affairs, HTA, Pharmaceutical Policy and Pricing
Private Payers: Group Benefits, Drug Benefit Solutions, Pharmacy Services, Health Benefits Strategy
Patient Groups: Senior Management, Patient Advocacy, Access and Equity
Healthcare: Patient Experience, Patient Relations, Patient-Centred Care Teams
Educational Institutions: Health Policy Researchers, Health Systems Programs